Aptevo Therapeutics
APVO
APVO
11 hedge funds and large institutions have $4.76M invested in Aptevo Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$392K | |
| 2 | +$155K | |
| 3 | +$152K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$115K |
Top Sellers
| 1 | -$150K | |
| 2 | -$123K | |
| 3 | -$86K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$25K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$13K |